01 / 04 / 2019
  - 10:47:38 AM
Rentschler Biopharma SE, Completes The Purchase Of The Former Shire Drug Manufacturing Facility In Milford

(Courtesy of the WB Journal) - Rentschler Biopharma SE, a contract development and manufacturing company for biopharmaceuticals, said Thursday that it has completed the purchase of the former Shire drug manufacturing facility in Milford. Financial terms of the deal were not disclosed, and a land transaction for the property was not recorded in the Worcester County Registry of Deeds as of Thursday. Rentschler Biopharma said it will continue to manufacturer for Ireland drugmaker Shire at the facility. The company plans to grow the development and manufacturing site as a contract development and manufacturing organization (CDMO) for complex biopharmaceuticals. The 70 employees working at the site for Shire will all be offered jobs, Rentschler Biopharma said. The site is the company's first outside of Germany. The 93,000-square-foot biomanufacturing facility on Maple Street was acquired in 2016 by Shire as part of its merger with Baxalta. The facility sale by Shire comes just after Japan's Takeda Pharmaceutical Co. announced its $59-billion acquisition of the company.

Contact Us

Phone: (508) 473-1490

Address: 258 Main Street
PO Box 421 Milford, MA 01757
Email: raywmrc@gmail.com

Public File

Advertise With Us

We offer an integrated, multi-platform program that combines the power and effectiveness of radio with the innovation and influence of the web.  Click HERE to learn more.